Sort the Following Results By:

$43M financing for Editas Medicine, Inc.
Represented the founders of Editas Medicine, Incorporated in a $43 million Series A Financing to fund the collaborative research and more Case Study
$12M financing for MVRx
Represented MVRx, a medical device technology company, in $12 million Series A financing by a strategic investor. more
Series Seed Financing for Infinite Uptime
Represent Infinite Uptime in Series Seed Financing by Mayfield. more
$40 million Series C Financing for Investors
Represent lead investors in $40 million Series C Financing of Hyperfine Research, Inc. more

*Experience gained by attorney prior to joining Kilpatrick Townsend

  • Case StudyCase Study
  • FeaturedFeatured
  • Pro BonoPro Bono

Who We Are

1080 Marsh Road
Menlo Park, CA, 94025
USA
t +1 650.462.5313
f +1 650.644.0477
9720 Wilshire Blvd PH
Beverly Hills, CA, 90212-2018
USA
t +1 310.777.3724

Carole H. Bellis

Experience Highlights

Series Seed Financing for Infinite Uptime
Represent Infinite Uptime in Series Seed Financing by Mayfield. more
$12M financing for MVRx
Represented MVRx, a medical device technology company, in $12 million Series A financing by a strategic investor. more
$43M financing for Editas Medicine, Inc.
Represented the founders of Editas Medicine, Incorporated in a $43 million Series A Financing to fund the collaborative research and more
$40 million Series C Financing for Investors
Represent lead investors in $40 million Series C Financing of Hyperfine Research, Inc. more